Transition together: a study of pediatric patients with sickle cell disease as they transition to adult health care by Musgrove, Lauren E
d 
TRANSITION TOGETHER: A STUDY OF PEDIATRIC PATIENTS WITH SICKLE 
CELL DISEASE AS THEY TRANSITION TO ADULT HEALTH CARE 
 
 
 
 
 
 
 
 
by 
Lauren Elise Musgrove 
BS, Cell and Molecular Biology, California State University, Sacramento, 2013 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
the Graduate School of Public Health in partial fulfillment  
of the requirements for the degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2015 
 
 UNIVERSITY OF PITTSBURGH 
Graduate School of Public Health 
 
 
This thesis was presented 
 
by 
Lauren Elise Musgrove 
 
 
It was defended on 
April 7, 2015 
and approved by 
Thesis Advisor: 
Beth Kladny, MS, LCGC 
Genetic Counselor, Magee Womens Hospital 
Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center 
 
Committee Members: 
Robin E Grubs, MS, PhD, LCGC  
Assistant Professor, Department of Human Genetics 
Director, Genetic Counseling Program 
Graduate School of Public Health, University of Pittsburgh 
 
Candace M Kammerer, PhD 
Associate Professor, Department of Human Genetics 
Graduate School of Public Health, University of Pittsburgh 
 
Patricia I Documet, MD, DrPH 
Associate Professor, Department of Behavioral and Community Health Sciences 
Scientific Director, Center for Health Equity 
Graduate School of Public Health, University of Pittsburgh 
 
 
 
 ii 
 Copyright © by Lauren Elise Musgrove 
2015 
 iii 
  
ABSTRACT 
Introduction: Improvement in medical care for sickle cell patients, translating into 
improvement in survival, has created the need for an active and intentional process of transition 
from pediatric to adult oriented health care. 
Objective: The purpose of this study was to determine the perspectives of adolescents 
and young adults with sickle cell disease as they prepare to transition, and to evaluate their 
current health care knowledge base and skills. 
Methods: A sample of 18 pediatric sickle cell patients age 15-22 years were recruited 
from a comprehensive Sickle Cell Center.  Two sections of a four part questionnaire containing 
open- and closed-ended questions were assessed in order to explore these patients’ expectations 
and concerns about the transition process, and to evaluate their self-management of sickle cell 
disease.  
 Results: Themes identified from the open-ended questions include: 1) Apprehension to 
Leaving Pediatric Care, 2) Forming New Relationships with Adult Providers, 3) Growing Up 
and Responsibility, 4) Worries Regarding Readiness and Support, and 5) Active Role in 
Transition.  Statistical analysis of the close-ended questions revealed that patients appeared to 
have similar levels of independence in performing skills related to “Knowledge of Health 
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 Issues/Diagnosis, “Being Prepared”, and “Taking Charge”.  However, there was a significantly 
lower level of independence in skills related to “Preparing for Legal/Other Issues After Age 18”.  
Overall, level of independence/readiness seemed to not be influenced by patients’ age, gender, or 
disease type. 
Discussion: Patients’ expectations and concerns about transition were mostly related to 
issues regarding patients’ perceived readiness for transition and the amount of support and 
understanding they receive from various health care providers.  Additionally, continued 
monitoring and addressing of items in which the patient states he/she needs assistance with to 
achieve independence will be essential in the transition process. 
Conclusions and Public Health Significance: Transition from pediatric to adult care 
providers is a crucial step in the care of individuals with sickle cell disease.  By eliciting the 
expectations and concerns of these patients’ and evaluating their knowledge base and skills, we 
are able to gather further insight into barriers to transition, and begin to develop a plan to address 
these obstacles. 
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 1.0  INTRODUCTION 
Sickle cell disease (SCD) is a genetic disorder that affects approximately 100,000 people in the 
United States (Molter & Abrahamson, 2014; Yawn, et al., 2014).  Although it can affect 
individuals of any ethnic/racial background, it is most often seen in individuals of African, 
Mediterranean, and Asian ancestry (Kanter & Kruse-Jarres, 2013).  Individuals with sickle cell 
disease experience acute and chronic periods of pain, organ dysfunction, and a decline in quality 
of life and life span.  Until the early 1970s, nearly 50% of children with sickle cell disease did 
not survive into adulthood (Andemariam, et al., 2014; Porter, et al., 2014).  However, with 
advancements in comprehensive medical care, 93% now reach the age of 18 years 
(Lebensburger, et al., 2012), and the majority live into their 40’s.  This improvement in medical 
care for sickle cell patients, translating into improvement in survival, has created the need for an 
active and intentional process of transition from pediatric to adult oriented health care. 
The Sickle Cell Clinic at Children’s Hospital of Pittsburgh of UPMC (CHP) has been 
identifying children with sickle cell disease and providing families with counseling, follow-up 
care and further genetic testing since 1978.  The clinic is staffed by an experienced team of 
medical professionals specialized in hematology/oncology, including a hematologist, physician 
assistant, nurse practitioners, nurses, social worker, genetic counselor, and behavioral health 
specialists.  The goal of the Sickle Cell Clinic is to identify these children as early as possible, in 
order to effectively manage their condition into adulthood. 
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 Furthermore, CHP’s Sickle Cell Staff has recently taken steps to establish a transition 
program. This program will help patients and families to connect with adult care providers at 
UPMC’s Adult Sickle Cell Program, which provides ongoing medical and psychosocial care for 
patients age 20 or older.  The objective of this study was to conduct a preliminary assessment of 
the perspectives, current health care knowledge base and skills of patients with sickle cell disease 
in the pediatric setting as they prepare to transition towards adult health care, focusing on the 
knowledge and understanding that will be necessary to participate in the management of their 
sickle cell health care needs. 
1.1 SPECIFIC AIMS  
1.1.1 Specific Aim 1 
To elicit adolescent and young adult sickle cell patients’ perspectives regarding transition from 
pediatric to adult care in order to determine their expectations and concerns about the transition 
process. 
1.1.2 Specific Aim 2 
To evaluate the knowledge base and skill sets of adolescent and young adult sickle cell patients 
in regards to their self-management of sickle cell disease health care needs, including 
management of a chronic disease, insurance, doctor appointments, medications, and legal issues. 
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 2.0  BACKGROUND AND SIGNIFICANCE 
2.1 SICKLE CELL DISEASE  
Sickle cell disease (SCD) refers to a group of inherited blood disorders (Hemoglobinopathies) 
characterized by the presence of abnormally shaped erythrocytes (red blood cells).   Hemoglobin 
(Hb) is the protein found in blood that is responsible for transporting oxygen throughout the 
body.  Additionally, hemoglobin plays a role in maintaining the shape of the erythrocytes.  When 
examined under a microscope, erythrocytes normally appear round. However, individuals with 
sickle cell disease also have erythrocytes that appear crescent-shaped or sickled.  The sickle-
shaped erythrocytes have a shorter life span than normal erythrocytes.  Additionally, they are 
more adherent and become lodged in blood vessels, thereby blocking the proper flow of blood.  
This results in the two key features of sickle cell disease, hemolysis and vaso-occlusion, which 
lead to tissue ischemia, pain crises, and multi-organ damage (Kanter & Kruse-Jarres, 2013).   
2.1.1 Molecular Genetics and Pathophysiology  
Hemoglobin consists of four globular protein subunits. In fetuses and infants, hemoglobin (Hb F) 
consists of 2 alpha-globin chains and 2 gamma-globin chains, α2γ2.  As the infant develops, the 
gamma-globin chains are slowly replaced by beta chains, forming the normal adult hemoglobin 
(Hb A), α2β2.  The α-globin chains are encoded by the the α-globin (HBA) gene found on 
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 chromosome 16 and the β-globin chains are encoded by the β-globin (HBB) gene found on 
chromosome 11 (Clarke & Higgins, 2000).  
Sickle hemoglobin (Hb S) results from a point mutation in the sixth amino acid of the 
HBB gene, which results in the formation of valine instead of glutamic acid (Glu6Val).   Hb S 
results in erythrocytes with a lower oxygen affinity, and increased polymerization upon 
deoxygenation.  This causes the erythrocytes to become misshapen  (i.e. sickle-shaped), fragile 
(i.e. hemolysis), and adherent, leading to blockage in the blood vessels (i.e. vaso-occlusion). 
The term sickle cell disease comprises a group of disorders characterized by the presence 
of at least one Hb S (βS) allele and a second abnormal hemoglobin allele (Table 2).  
Homozygosity for βS, HbSS, is referred to as sickle cell anemia (SCA) and is the most common 
and severe form of SCD.  Sickle cell disease can also be inherited through compound 
heterozygosity of βS and other mutant β-globins, most commonly hemoglobin C (Hb C).  Hb C is 
formed from a point mutation in the sixth amino acid of the HBB gene, which causes the 
substitution of lysine from glutamic acid (Glu6Lys), and results in sickle cell hemoglobin C 
disease (HbSC).  Other β-globin chain variants such as Hb D-Punjab (Glu121Gln), Hb O-Arab 
(Glu121Lys) and Hb E (Glu26Lys) are less common, and also result in sickle cell disease when 
co-inherited with Hb S (Bender & Douthitt Seibel, 2003; Clarke & Higgins, 2000).  Mutations in 
the HBB gene that result in reduced amounts of (β+) or absent (β0) β–globin chains are referred to 
as Beta-Thalassemias, and when inherited with Hb S result in Sickle Cell Beta-Thalassemias 
(HbSβ0 and HbSβ+).  
 
 
 4 
Table 1. Common Sickle Cell Disease Genotype-Phenotype Correlations 
Name (Abbreviation) Alleles Involved Disease Severity Characteristics 
Normal (HbAA) β and β None Hb A (Normal Adult Hemoglobin) 
Sickle Cell Anemia 
(HbSS) 
βS and βS Severe Hb S (Glu →Val) 
The most common and severe form of SCD 
Sickle-Hb C Disease 
(HbSC) 
βS and βC Moderate Hb S and Hb C (Glu →Lys) 
Sickle-β0-Thalassemia 
(HbSβ0) 
βS and β0-Thal  
(severe  mutation) 
Severe Hb S and Hb β0-Thal (Absent β-globin 
chains) 
Sickle-β+-Thalassemia 
(HbSβ+) 
βS and β+-Thal  
(moderate mutation) 
βS and β+-Thal  
(mild mutation) 
Mild to Moderate Hb S and Hb Β+-Thal (Reduced amounts of 
β-globin chains)  
(Adapted from Bender & Douthitt Seibel, 2003; Clarke & Higgins, 2000) 
2.1.2 Inheritance 
Sickle cell disease is inherited in an autosomal recessive manner.  For an individual to be 
affected, he/she must inherit mutations in both copies of the HBB gene (i.e. one from each 
parent).  If an individual only has one mutation then he/she is said to have sickle cell trait (SCT), 
and are not affected.  However, he/she is a carrier for SCD and has a 50% (or 1 in 2) chance of 
passing on the mutation to their child.  When both parents are carriers than there is a 25% chance 
(or 1 in 4) that they will have an affected child, a 50% chance (or 1 in 2) that they will have a 
child who is a carrier of SCT, and a 25% chance (or 1 in 4) that the child will not be affected or a 
carrier.   
5 
2.1.3 Diagnosis 
A diagnosis of sickle cell disease may be established through a variety of methods including 
hemoglobin electrophoresis, isoelectric focusing (IEF), high performance liquid chromatography 
(HPLC), and DNA analysis (Clarke & Higgins, 2000; Rees, 2010). Most often, an initial 
diagnosis is achieved through detecting significant amounts of Hb S through HPLC or IEF.  
Molecular genetic testing of the HBB gene through sequence analysis, deletion/duplication 
analysis, and targeted mutation analysis may be performed in order to confirm a diagnosis of 
sickle cell disease, test carriers, and perform prenatal diagnosis when there is a known familial 
mutation (Bender & Douthitt Seibel, 2003). 
2.1.4 Clinical Manifestations and Management 
As a result of the characteristic hemolysis and vaso-occlusion, sickle cell disease is a chronic, 
multisystemic condition associated with numerous health issues. Chronic hemolysis results in 
hemolytic anemia, which can manifest as pulmonary hypertension, priapism, and leg ulcers. 
Vaso-occlusion is associated with tissue ischemia that results in pain crises in the chest, 
abdomen, back, and extremities. These pain crises are frequent problems in pediatric sickle cell 
patients, are the most common reason sickle cell patients are admitted to the hospital, and are a 
significant source of morbidity and mortality (Rees, et al., 2010; Wilson & Nelson, 2014).  
Treatment of pain crises in the clinical setting typically involves a combination of strategies 
including intravenous fluids, intravenous pain medication, and non-pharmacological techniques, 
such as heat packs and breathing exercises (Meier & Miller, 2012). Therefore, pain management 
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 is multifaceted, and includes pharmacologic, physical, and psychological approaches (Wilson & 
Nelson, 2014).     
Other complications include dactylitis (pain and/or swelling of the hands or feet), splenic 
sequestration and infarction, stroke, cerebral infarcts, intracranial hemorrhage, and kidney failure 
(de Montalembert, et al., 2014; Meier & Miller, 2012).  Over time, these complications can lead 
to damage in numerous organs throughout the body including the spleen, lungs, kidneys, and 
bones.   Damage to the spleen increases the risk of infection and sepsis, which in turn is the 
leading cause of death in children with sickle cell disease (Meier & Miller, 2012).  Due to the 
increased risk of infections, standards of care include initiation of prophylactic penicillin upon 
diagnosis.  Immunizations are also essential for those with sickle cell disease.  Other 
complications of sickle cell disease often require treatment through proper hydration, pain 
medication, and blood transfusions (Wilson & Nelson, 2014).   
Currently, Hydroxyurea is the first and only FDA approved medication for prevention of 
sickle cell disease related complications.  The principle mechanism of this drug is that it 
increases the production of Hb F, which inhibits the polymerization of Hb S (Kanter & Kruse-
Jarres, 2013).  In turn, this reduces hemolysis and prevents acute vaso-occlusion.  As a result, 
Hydroxyurea has been found to reduce the frequency of pain crises, acute chest syndrome, and 
transfusions by ~50% (Quinn, 2013).  Previously used as a chemotherapeutic agent, side effects 
of Hydroxyurea are typically mild.  These include dose-related leukopenia (decreased white 
blood cell counts) and thrombocytopenia (decreased platelet counts) (Rees, 2010).  The side 
effects are reversible, and so patients who are on Hydroxyurea are closely monitored.  
Hematopoietic stem cell (or bone marrow) transplantation is the only curative treatment.  
Unfortunately, it is currently only recommended for children with HLA-compatible siblings.  In 
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 all, management of sickle cell disease requires a multidisciplinary team approach, in which care 
coordination is necessary to improve clinical outcomes and overall survival of patients (Hankins, 
et al., 2012). 
2.2 TRANSITION 
2.2.1 Background 
In an American Academy of Pediatrics (AAP) Survey performed in 2008, pediatric providers 
noted that 84% of youth/young adults with special health care needs lacked knowledge about 
their medical condition, and only 12% of the providers surveyed created individualized transition 
plans for their patients (McManus, et al., 2008).  In one of the first studies of sickle cell disease 
health care transition, issues, concerns, and expectations of adolescents and young adults, parents 
or guardians were investigated as they related to the transfer to adult care.  The young adults with 
sickle cell disease were concerned about how they would pay for medical care and how they 
would be treated in the adult setting (Bryant & Walsh, 2009).  Their caregivers were concerned 
regarding the youth’s ability to take on responsibility for self-care and cope successfully in the 
adult health care system.  In a multi-site study of sickle cell transition in sickle cell centers and 
community-based SCD programs, the majority of patients voiced fear of leaving their pediatric 
health care providers, concerned that the adult providers might not understand their needs and 
might not believe their complaints of pain (Cerns, et al., 2013). 
Often, in the past, age has determined when transfer of care has occurred, rather than an 
individual assessment of patient readiness or compliance (Sobota, et al., 2011).  Data reveals 
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 little progress has been made in transition from pediatric to adult health care in the last decade 
despite a 2002 Consensus statement by the American Academy of Pediatrics (AAP)/American 
Academy of Family Physicians (AAFP)/American College of Physicians (ACP) which included 
the identification of six critical steps to ensuring successful transitioning to adult-oriented health 
care. These steps consisted of: “1) ensuring that all young people with special health care needs 
have an identified health care professional who attends to the unique challenges of transition, 2) 
identifying the core knowledge and skills required for transition, 3) preparing and maintaining an 
up-to-date medical summary that is portable and accessible, 4) creating a written health care 
transition plan by age 14 together with the young person and family, 5) applying the same 
guidelines for primary and preventive care for all adolescents and young adults, including those 
with special health care needs, and 6) ensuring affordable, continuous health insurance coverage”  
(American Academy of Pediatrics, et al., 2002).  
2.2.2 Significance 
In 2011, a clinical report by the AAP, AAFP, and the ACP was published which provides 
practical, detailed guidance with an algorithm on how to plan and implement better health care 
transitions for all patients. Furthermore, it integrates transition planning into the medical home 
and into ongoing chronic care management through identification of six core elements of health 
care transition: 1) transition policy, 2) transition tracking and monitoring, 3) transition readiness, 
4) transition planning, 5) transfer of care, and 6) transfer completion (American Academy of 
Pediatrics, et al., 2011).  When asked, 62% of pediatric providers thought transition planning for 
their patients should begin at 18-20 years of age for those patients with special needs, and 65% 
of pediatric providers said this same age bracket would be the best time to begin transition 
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 planning for those patients without special needs (McManus, et al., 2008; Cooley & Sagerman, 
2011).  Yet, the literature shows transition planning should begin at a much earlier age between 
13-14 years old for the best outcome (American Academy of Pediatrics, et al., 2011; Treadwell, 
et al., 2011).  All youth must navigate rapidly changing, physical, psychological and social 
issues as they move forward towards independence, but those with sickle cell disease, as well as 
other chronic medical conditions, will need additional support as they must also adjust to taking 
on increasing responsibility in the management of what is a lifelong condition (Cerns, et al., 
2013; van Staa, et al. 2011; Wills, et al., 2010).  So, it is believed that preparation for transition 
should start early and focus on strengthening adolescent independence without undermining 
parental involvement (van Staa, et al. 2011). 
2.2.3 Establishment of a Transition Program 
According to the Centers for Disease Control and Prevention’s (CDC) national resource 
directory, as of April 2013 there are 184 pediatric and 54 adult providers/sickle cell centers 
nationwide.  This data would indicate that most adult sickle cell patients are cared for outside of 
a designated sickle cell center.  Additionally, in 2011, a multi-site study of pediatric sickle cell 
clinics was conducted.  The aim of this study was to describe the current transition practices of 
these clinics in order to identify areas for improvement.  Of the 30 pediatric sickle cell clinics 
surveyed, only 18 reported that they routinely transferred their patients to an adult hematologist 
specializing in sickle cell disease (Sobota, et al., 2011). 
In an effort to provide a smooth and successful transition process from pediatric to adult 
oriented care, CHP’s Sickle Cell Staff has recently taken steps to establish a transition program. 
The planned transition program will focus on health literacy, disease self-management skills, 
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 improving communication skills with health care providers, and life planning.  It will implement 
a newly designed survey tool, in conjunction with a motivational interviewing style, to assess 
and evaluate the program.  The survey tool is a four part questionnaire that contains a portable 
medical summary in addition to a readiness assessment tool, which will be updated at each visit.  
The portable medical summary prevents duplication of test and procedures, and helps streamline 
the information gathering process for providers. This in turn improves patient safety, and ensures 
adult providers have accurate information.  Motivational interviewing will be conducted by a 
trained health care professional who is a member of the research team, and will be utilized 
during transition clinic visits.  This is a patient-centered approach that will be used with the 
intent to elicit and strengthen the patient’s own motivations for behavioral changes towards 
successful transition.  Motivational interviews will be audio taped for transcription and analysis.  
It is expected that some conversations may reveal more in-depth understanding of patients’ needs 
than what the survey tool is able to capture. 
 By implementing this transition program, the Sickle Cell Clinic hopes to achieve greater 
involvement from patients and families so they may learn how to utilize their own skills and 
abilities in managing their health care and health care needs, as well as strengthening the 
independence of youth/young adults with sickle cell disease as they move forward towards 
maturity with regards to their own health care.  This survey instrument also allows for the 
collection of data regarding the perceptions of sickle cell patients being seen at Children’s 
Hospital of Pittsburgh, who are 15 years of age and older, about the process of transition from 
pediatric to adult medical care for their sickle cell disease. 
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 3.0  STUDY DESIGN AND METHODS 
3.1 PROJECT DEVELOPMENT 
This project was conducted through collaboration with the Sickle Cell Clinic at Children’s 
Hospital of Pittsburgh of UPMC (CHP).  As part of the establishment of the transition program, 
an ongoing study will be conducted that will collect data regarding the transition process of 
medical care for sickle cell patients from pediatric to adult oriented care.  The study was most 
recently reviewed and approved by the University of Pittsburgh Institutional Review Board on 
August 13th 2014 identified as IRB #PRO13030461 (See Appendix A).  Prior to the full 
establishment of the clinic’s transition program, an initial round of transition questionnaires were 
distributed to eligible patients who had agreed to be in the study.  This project was designed as a 
substudy to conduct a preliminary assessment of these previously collected questionnaires to 
determine patients’ perspectives on transition and the level of independence they had regarding 
various skills essential to transition and self-management of their sickle cell health care needs.    
3.2 PATIENT POPULATION 
The patient population consisted of male and female patients who were evaluated by members of 
the research/health care team of the Sickle Cell Clinic at Children’s Hospital of Pittsburgh.  
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 Inclusion criteria consisted of being a patient with sickle cell disease between the ages of 15-22 
years seeking care at the CHP Sickle Cell Clinic.  An exclusion criterion was any patients under 
the age of 15.   
3.3 PATIENT RECRUITMENT 
Patients of the Sickle Cell Clinic at the Children’s Hospital of Pittsburgh must transfer to adult 
care by the age of 22 years.  As transition is an active process that requires gaining 
independence, which can only take place over time, it is suggested that the patients begin the 
process of transition at 15 years of age.  Patients age 18 to 22 years and parents of patients aged 
15 to under 18 years who receive sickle cell health care at the CHP Sickle Cell Clinic were 
mailed letters via the US postal service introducing them to the study.  This letter was sent by 
members of the clinic’s research team, which includes the physician, social worker, case 
manager, and nurse practitioner, all of whom are known to the patients who seek care at the CHP 
Sickle Cell Clinic.  Patients were then approached by a member of the research team, who is also 
part of the health care team, during a regularly scheduled clinic appointment.  Patients and 
parents as applicable received an explanation of the study, and were offered the opportunity to 
enroll in the study after review of consent.  
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 3.4 INFORMED CONSENT 
A member of the research team provided an introduction/review of the research study, including 
potential risks and benefits, protocol procedures, and research team expectations.  Patients, and 
as applicable parents/legal guardians were encouraged to ask questions.  Patients/parents were 
given the opportunity to speak to the principal investigator (PI) prior to enrollment, if requested.  
Consent was then obtained from patients 18 years of age and older, and from a parent/legal 
guardian for patients under 18 years of age following the patient’s assent.  A copy of the signed 
consent was given to all patients, as well as parent/legal guardian as applicable.  
3.5 SAMPLE 
At the time of the study, the CHP Sickle Cell Clinic had 30 patients identified as meeting the 
inclusion criteria, and 25 of these individuals consented to being in the study.  Of these 25 
patients, 18 of them completed the portions of the self-administered questionnaire pertaining to 
their thoughts on transition and skill sets. 
3.6 SURVEY TOOL 
Patients with sickle cell disease being treated at the Sickle Cell Clinic at Children’s Hospital of 
Pittsburgh who were between the ages of 15-22 years, and who had consented to being in the 
study received a self-administered four part questionnaire during a regularly scheduled visit. The 
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 questionnaire was created by members of the CHP Sickle Cell Program, and was adapted for the 
sickle cell population from the customizable, standardized readiness assessment tool provided by 
Got Transition/Center for Health Care Transition (A cooperative agreement between the 
Maternal and Child Health Bureau and the National Alliance to Advance Adolescent Health).  
The customizable readiness tool has been assessed by the National Quality Forum’s measure 
evaluation criteria and process, and was found to have good internal reliability and criterion 
validity (McPheeters, et al., 2014; National Health Care Transition Center, 2015). 
The four part questionnaire consisted of a portable medical summary and patient 
readiness tool.  The portable medical summary (section 1) included questions regarding 
demographic information.  The patient readiness tool was subdivided into two fill in the blank 
sections regarding the patients’ thoughts on transition and their strengths (sections 2 and 3), as 
well as a quantitative section regarding their skill sets (section 4).  This project focused solely on 
the portions of the transition questionnaire regarding patients’ thoughts on transition (section 2) 
and their various skill sets (section 4). 
Section 2: Thoughts About Transition (See Appendix B) 
Consisted of five open-ended questions inquiring about patients’ thoughts on transition.   
Section 4: Skill Sets (See Appendix C) 
Consisted of thirty-eight close-ended questions that elicited information pertaining to four 
categories: 1) Knowledge of Health Issues/Diagnosis, 2) Being Prepared, 3) Taking Charge, and 
4) Preparing for Legal/Other Issues After Age 18.  Answers were recorded on a 3-point Likert 
scale (“I always depend on other to do this for me”, “I am currently learning to how to do this 
independently”, “I can do this independently”) and were scored from 1 to 3. 
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3.7 DATA ANALYSIS 
Section 2: Thoughts About Transition 
 The open-ended questions inquiring about patients’ perceptions on transition resulted 
in qualitative data, which was evaluated using thematic analysis.  Responses were reviewed 
and analyzed to determine repeating themes.  This was done by coding and interpreting the 
data through a series of steps involving: 1) reading through all the responses, 2) 
developing categories, 3) assigning each response to a category, 4) checking the categories, 5) 
reviewing for major themes, 6) identifying patterns and trends, and 7) writing-up the analysis  
(Braun & Clark, 2006). 
Section 4: Skill Sets 
Likert scales were used in order to quantify the level of independence of the various skills 
pertaining to transition from pediatric to adult care.  The overall level of independence of each 
patient was analyzed by taking each response from the 38 skill set questions, converting them to 
a numerical value (1-3), and then finding the average of these values.  The average level of 
independence of the patients were then compared across the various skills set, and demographic 
characteristics (i.e. age, gender, and disease type/severity).  Non-parametric tests were used for 
these comparisons given the small sample size and the assumption that the data would not follow 
a normal distribution.  The Mann-Whitney test was used for comparisons of the medians 
between two groups (i.e. by age and gender), while the Kruskal-Wallis test was used for 
comparisons of the medians between more than two groups (i.e. between the skill sets and by 
disease type).  All statistical analysis was carried out using Microsoft ® Excel and Minitab 16.0 
statistical software.  
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 4.0  RESULTS 
4.1 DEMOGRAPHICS 
A total of 18 adolescents and young adults with sickle cell disease were surveyed (Table 2).  
Table 2. Summary of Patient Characteristics 
Variables                                                             N (%) 
Sex 
 Male                                                              3 (16.7) 
 Female                                                         15 (83.3) 
Race/Ethnicity 
 African American                                        18 (100) 
Age (y) 
 <18                                                                 5 (27.8) 
 18-22                                                            13 (72.2) 
 Average age (y)                                               18.6 
Sickle Cell Diagnosis 
 HbSS                                                              6 (33.3) 
 HbSC                                                             8 (44.4) 
 HbSβ0Thal                                                     0 (0) 
 HbSβ+Thal                                                     3 (16.7) 
 Unknown                                                       1 (5.6) 
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 The majority of patients were 18 years or older (72.2%), with an average age of 18.6   
(SD = 2.1) years.  Among the patients, 15 (83.3%) were female and 3 (16.7%) were male.   All 
patients were of African American racial/ethnic background.  As far as sickle cell disease type, 6 
(33.3%) had HbSS, 8 (44.4%) had HbSC, 3 had (16.7%) HbSβ+Thal, and 1 (5.6%) individual did 
not report on their sickle cell disease type, and so their diagnosis is unknown. (See Figures 1-5). 
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Figure 1. Age Distribution of Patients 
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Figure 2. Age Group Distribution of Patients 
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Figure 3. Gender Distribution of Patients 
 
 
 21 
  
Figure 4. Disease Type of Patients 
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4.2 THOUGHTS ABOUT TRANSITION 
Of the 18 patients surveyed, 17 (94.4%) answered the questions in section 2 of the transition 
questionairre.  Table 3 displays the responses to the five open-ended questions regarding 
transition.  
Table 3. Patients' Responses to Open-Ended Questions Regarding Transition 
What are the good 
things about 
transitioning? 
What are the not so 
good things about 
transitioning? 
What is the best 
thing that will 
happen to you when 
you will transition? 
What is the worst 
thing that you see 
happening you to 
when you 
transition? 
Can you state at 
least one thing that 
you have done in 
the past 6 months 
to improve the 
transition process? 
You are treated as 
you should be at 
your age 
Less comfortable 
with the doctors and 
the hospital 
Not sure The new treatment 
team will be 
compassionate 
Attend a clinic 
I'll be in an adult 
hospital 
None of the people 
I'm used to 
I'll be more of an adult People don't adjust 
too well 
Made it to my 
appointments 
I will be better 
equipped to handle 
myself in the future 
I can' t think of 
anything 
I'll be able to go 
anywhere  
Nothing No 
IDK IDK IDK IDK IDK 
No idea New doctors and 
nurses 
I have no clue Nothing No 
Knowing that I am 
growing up and 
healthy 
Having to leave the 
hematology team 
that I have grown to 
know and love 
Getting a new team of 
doctors  
Having to explain 
things that my 
pediatric team 
already knows, or 
not being 
understood 
Make my 
appointment! 
I don’t know -  
nothing 
Losing my doctors 
[that] helped me 
grow up 
I somehow will get to 
keep my doctor 
I lose my doctor Came to clinic 
Getting to know new 
people 
None I don’t know None None 
No response No response No response No response No response 
It helps patients 
become more 
independent and 
knowledgeable 
Nothing I can think 
of 
I will be more 
independent 
I will try to solve a 
crisis on my own 
I write down my 
medications and 
doses, my doctors 
and their numbers, 
and my 
appointments 
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Valuable 
information being 
shared about sickle 
cell, known and 
unknown facts 
Leaving the 
wonderful care team 
I have grown to love 
Moving forward with 
my illness 
N/A Stay in contact with 
doctors 
Good experience Different 
surroundings 
No response Being on my own 
at the hospital 
No response 
It’s good because 
your moving onto 
The adult world, 
getting older and 
growing wiser 
You’re leaving 
children's hospital 
Where they know 
me best and [have] 
work with most of 
your life and have to 
meet a new team of 
doctors 
The same day clinic Transitioning too 
early, not being 
Ready to move 
forward to the 
adult world 
Transition classes 
Welcomes me to the 
real world/adulthood 
We knew all the 
doctors and nurse 
well 
I'm not sure Not getting along 
with nurses and 
doctors 
No 
I can experience 
adulthood 
Meeting new people IDK The doctors not 
knowing me very 
well 
No 
Nothing Don't  know the 
people/staff, no 
Disney movies, pay 
for tv, not as fun 
food 
Can't think of 
anything 
Mistreatment I showed up today 
Be more 
independent, handle 
my medication on 
my own 
Scary, probably less 
support than with 
CHP staff 
Can't think of 
anything 
That I will be 
alone, I will not be 
able to talk to you 
guys 
Come to clinic 
The good things are 
the excitement of 
having a new doctor 
and new experiences 
The doctors not 
knowing me 
personally and not 
understanding my 
life outside of the 
hospital 
I will have a new 
experience with 
someone new 
Awkward moments 
between me and 
my new doctor 
Have not started yet 
After reviewing the responses, most of the answers the patients gave about their 
expectations and concerns regarding transition appeared to fall into two categories: health care-
related issues and patient-related issues.  Amongst these two categories, four themes were 
identified: 1) Apprehension to Leaving Pediatric Care, 2) Forming New Relationships with Adult 
Providers, 3) Growing Up and Responsibility, and 4) Worries Regarding Readiness and Support. 
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Table 3 Continued
 4.2.1 Health Care-Related Issues 
Apprehension to Leaving Pediatric Care 
When asked to name some of the not so good things regarding transition, seven of the patients 
mentioned leaving their current health care team. Responses included:  
“Having to leave the hematology team that I have grown to know and love”,  
“Losing my doctors [that] helped me grow up”, and 
“You’re leaving children’s hospital where they know me best and [have] work with most of your 
life and have to meet a new team of doctors”. 
Two patients stated that no longer having their current doctor/health care team was the worst 
thing about transition, claiming: 
“Having to explain things that my pediatric team already know, or not being understood”, and 
“I lose my doctor”. 
 
Forming New Relationships with Adult Providers 
Another theme that appeared to reoccur was patients’ perspectives on forming new relationships 
with adult providers.  Patients made comments that were both positive and negative regarding 
this theme.  When asked what some of the good things about transitioning were, two patients 
replied, 
“Getting to know new people”, and   
“The good things are the excitement of having a new doctor and new experiences”. 
Additionally, two patients mentioned that the best thing that will happen when they transition is: 
“Getting a new team of doctors”, and 
“I will have a new experience with someone new”. 
 25 
 On the other hand, this was mentioned as one of the not so good things about transition 
by five patients.  Comments from these individuals included: 
“Less comfortable with the doctors and the hospital”, and 
 “The doctors not knowing me personally and not understanding my life outside of the hospital”. 
Furthermore, not having an established relationship with adult health care providers was reported 
as the worst part of transitioning by three of the patients surveyed.  These individuals expressed 
concern about: 
“Not getting along with nurses and doctors”, 
“The doctors not knowing me well”, and 
“Awkward moments between me and my new doctor”. 
4.2.2 Patient-Related Issues 
Growing Up and Responsibility 
A theme that appeared to be a positive aspect of transitioning was the move into adulthood and 
gaining independence.  Nine patients reported this issue as one of the good things about 
transition, stating that: 
“You are treated as you should be at your age”, 
“It helps patients become more independent and knowledgeable”, and 
“It’s good because you are moving onto the adult world, getting older and growing wiser”. 
Additionally, it was mentioned as the best part of transition by four patients.  Responses 
included: 
“I’ll be more of an adult”, and 
“Moving forward with my illness”. 
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Worries Regarding Readiness and Support 
A theme that appeared to be an overwhelming negative aspect of transitioning was worries 
regarding readiness for transition and the level of support that will be in place.  This theme was 
mentioned as one of the not so good things about transition by a patient, who stated: 
“Scary, probably less support than with CHP staff”. 
Additionally, it was mentioned as the worst part of transition by five patients.  Responses 
included concerns that: 
“People don’t adjust too well”, 
“That I will be alone”, 
“I will try to solve a crisis on my own”, and 
Transitioning too early, not being ready to move forward to the adult world”. 
4.2.3 Active Role in Transition 
Lastly, patients were asked if they could state one thing that they have done in the past 6 months 
to improve the transition process.  Of the ten patients who answered this question in the 
affirmative, all of them mentioned something that involved them taking an active role in their 
health care management.  This was done either by attending their appointments/clinic, being in 
contact with their doctors, or writing down their important health information (i.e. medications 
and doses, appointments, etc.). 
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 4.3 KNOWLEDGE BASE AND SKILL SETS 
4.3.1 Knowledge of Health Issues/Diagnosis 
Figure 5 summarizes the results from the 14 “Knowledge of Health Issues/Diagnosis” questions.  
The majority of patients, 88.9%, could explain the type of sickle cell disease they have and 
72.2% stated that they understood their diagnosis and health history, and could explain it to 
others.  83.3% reported that they know and can state the significant health problems caused by 
their sickle cell disease, while only 61.1% knew what their other non-sickle cell diagnoses were.  
In regards to communicating with a new provider, 77.8% reported that they could explain their 
health care needs and medical treatments, while 83.3% could state what medications they have 
been prescribed.  Additionally, 88.9% of patients knew how to pick up their medicine from the 
pharmacy. 55.6% knew when they last saw each specialist, and only 27.8% knew their 
hemoglobin and reticulocyte level baseline, as well as their pulse oximeter baseline number.  
However, 94.4% recognized which of their symptoms needed quick medical attention, and what 
to do in case they have a medical emergency.  It is important to note that this skill set measured 
patients’ perception of their knowledge, and not their actual level of knowledge. 
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Figure 5. Patients' Self-Reported Levels of Independence Regarding Knowledge of Health Issues/Diagnosis 
 
4.3.2 Being Prepared 
Figure 6 summarizes the results from the 4 “Being Prepared” questions. 72.2% of patients 
reported that they carry their health insurance card every day, and 66.7% knew what type of 
medical coverage they have.  When asked if they either carry or know where to get their 
important health information, 55.6% of patients stated that they did.  Lastly, of the patients that 
were 18 years or older, 46.2% claimed that they have an adult primary care physician. 
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Figure 6. Patients' Self-Reported Levels of Independence Regarding Being Prepared 
4.3.3 Taking Charge 
Figure 7 summarizes the results from the 13 “Taking Charge” questions.  72.2% of patients 
stated that they call and make their own doctors’ appointments, and 88.9% use a cell phone or 
calendar to remind them of their appointments and medication refills.  77.8% reported that they 
knew that they have an option to see their doctor by themselves, and 61.1% prepare written 
questions to ask prior to a doctor’s appointment.  Additionally, 94.4% said that they could read a 
prescription label.  However, only 50% track their own appointment and prescription refill 
expiration dates, and 66.7% call in their own prescriptions refills.  88.9% can state where they 
typically experience pain during a pain episode, and 72.2% know how to manage their pain and 
diagnosis at home.  94.4% know what medications help to manage their pain, and how to take 
these medications.  Furthermore, 72.2% know what non-medication steps to take to help manage 
their pain, and 61.1% know stress reduction or relaxation techniques that help main their pain.   
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Figure 7. Patients' Self-Reported Levels of Independence Regarding Taking Charge 
4.3.4 Preparing for Legal/Other Issues After Age 18 
Figure 8 summarizes the results from the 7 “Preparing for Legal/Other Issues After Age 18” 
questions.  44.4% of patients stated that they have a plan to keep their health care insurance or 
obtain medical coverage after they turn 18.  27.8% reported that they have a plan to develop a 
legal Power of Attorney for health care decisions in the event that their health changes and they 
are unable to make decisions for themselves.  38.9% claimed that they knew of resources that 
can help them to find adult services (i.e. job support, transportation, assistive technology, etc).  
44.4% stated that they knew how their condition may affect job choices, and 38.9% knew what 
benefits they might qualify for (i.e. SSI, community based services, etc).  Lastly, 55.6% said they 
knew their options for housing as an adult, and 44.4% knew how to manage their money and pay 
their bills. 
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Figure 8.  Patients' Self-Reported Levels of Independence/Readiness Regarding Preparing for Legal/Other 
Issues After Age 18 
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 4.4 INDEPENDENCE/READINESS ASSESSMENT 
4.4.1 Responses by Skill Set 
The medians of the average levels of independence for each of the skill sets were compared to 
each other, and were 2.72, 2.51, 2.72, and 2.24 for Knowledge of Health Issues/Diagnosis, Being 
Prepared, Taking Charge, and Preparing for Legal/Other Issues After Age 18, respectively 
(Figure 9).  The Kruskal-Wallis test was used to compare these groups.  The distribution 
amongst the four groups did differ significantly (H = 16.06, p-value (0.001) < 0.05).  The level 
of independence in doing the tasks mentioned in the “Preparing for Legal/Other Issues After Age 
18” skill set was significantly lower than those in the other skill sets. 
Taking ChargeKnowledgeBeing PreparedAfter 18
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I am currently learning to do this independently  2
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Figure 9. Comparison of Patients' Independence/Readiness Across the Various Skill Sets 
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 4.4.2 Responses by Age 
The median levels of independence were 2.43 and 2.68 for under 18 years of age and ≥18 years 
of age and older, respectively (Figure 10). The Mann-Whitney test was used to compare these 
two groups.  The distribution of these two groups did not differ significantly (W=30.5, p-value 
(0.1039) > 0.05).   
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Figure 10. Comparison of Patients' Independence/Readiness by Age 
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4.4.3 Responses by Gender 
The median levels of independence for females and males were 2.63 and 2.61, respectively 
(Figure 11). The Mann-Whitney test was used to compare these two groups.  The distribution in 
the two groups did not differ significantly (W=28.5, p-value (1.0000) > 0.05).   
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Figure 11. Comparison of Patients' Independence/Readiness by Gender 
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4.4.4 Responses by Disease Type/Severity 
The median levels of independence were 2.66, 2.43, 2.84, and 2.43 for SS, SC, Sβ+-Thal and 
unknown, respectively (Figure 12).  The Kruskal-Wallis test was used to compare these groups.  
The distribution amongst the four groups did not differ significantly (H = 2.42, p-value (0.490) > 
0.05).   
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Figure 12. Comparison of Patients' Independence/Readiness by Disease Type 
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 5.0  DISCUSSION 
5.1 SPECIFIC AIM 1 
This project sought to elicit the perspectives of sickle cell patients’ in a pediatric setting 
regarding transition, in order to determine their expectations and concerns about the transition 
process. In general, a major barrier to transition is a lack of transitional support.  (Bryant & 
Walsh, 2009).   Additionally, this issue has been frequently emphasized in research regarding 
transition in the sickle cell population.  Previous studies have shown that a major barrier to 
successful transition for these patients is a lack of adult hematology providers with expertise or 
interest in sickle cell disease (Andemariam, et al., 2014; Sobota, et al., 2011).  Despite the fact 
that there is a dedicated adult hematology program that collaborates with the pediatric sickle cell 
clinic at CHP, a major worry expressed by the patients in this study was a concern about the 
level of support that they would receive from adult providers.  These concerns are founded, 
given that there are significant gaps between the cultures of care in pediatric and adult care.  A 
few of these differences noted in the literature include the amount of time patients may have to 
wait to be seen by an adult provider and the length of clinic appointments, as well as potential 
under treatment of symptoms when information regarding their pain management plan is not 
available. This is due to the fact that patients are often perceived as drug seeking  when 
presenting for treatment of pain crises (Cerns, et al., 2013; Wilson & Nelson, 2014).  The 
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 implementation of various peer-based activities is one strategy that could be used to address this 
barrier.  The utilization of a buddy system in which patients preparing to transition are paired 
with someone who has already gone through the transition process could potentially alleviate 
some of these concerns and expectations.  By being able to hear firsthand accounts of patients’ 
experiences with the adult care system, individuals would be able to find out whether their fears 
are truly justified or not. Additionally, group meetings in the pediatric setting in which 
individuals can freely express their concerns with other patients preparing to transition may also 
prove helpful.  Moreover, these group meetings do not necessarily have to be something that is 
organized by the clinic itself.  For example, the CHP Sickle Cell Clinic has a partnership with a 
local community-based organization, the Children’s Sickle Cell Foundation (CSCF).    At 
specific times throughout the year, CSCF holds a month-long transition program for young 
adults with sickle cell disease.  This program is an additional source of support and educational 
opportunities for continued development.  Providing patients with information about this 
program is another resource that could be offered by the CHP Sickle Cell Clinic. 
The research that has evaluated the limited transition programs that currently exist has 
stressed the importance of implementing a comprehensive plan to successfully transition 
patients.  This includes the development of formal transition programs by individual institutions, 
and the establishment of transition policy that defines the expected age of transfer, and the 
responsibilities for all stake holders during transfer (de Montalembert, et al., 2014).  
Additionally, the importance of contact with adult providers and health care centers prior to 
transition has been repeatedly mentioned.  The results of this study further support these findings 
given that the main concerns expressed by patients in this study regarding their health care 
management were leaving their current doctor/health care team and establishing new 
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 relationships with adult providers.  These individuals were fearful of leaving the providers that 
they had grown accustomed too, and who they felt understood them.  This has been reported in 
the transition literature (Cerns, et al., 2013, Jordan & Coates, 2013; Smith, et al., 2011).  
Although some patients were excited about the opportunity to work with new providers, the 
majority were hesitant about forming new relationships with these providers. Suggestions to 
address this barrier mentioned in the literature include better communication between pediatric 
and adult providers  (van Staa, et  al. 2011), and having patients meet with adult providers prior 
to transition (Hankins, et al., 2012; Jordan & Coates, 2013; McPherson, et al., 2009; Tuchman, et 
al., 2008) .  Therefore, a recommendation for the CHP transition program based on the findings 
of this study would be to take full advantage of the collaborative relationship that exists between 
the pediatric and adult hematology programs within the UPMC health care system.  This would 
consist of taking such measures as increased communication between pediatric and adult health 
care providers, and creating opportunities for patients to meet the new health care team and/or 
visit the adult-oriented health care facility prior to transitioning. 
 Lastly, the aspect of transition that most of the patients appeared to be looking forward to 
was gaining independence and transitioning into adulthood. Similar findings have been 
documented in the literature; while patients are apprehensive about making the transition to adult 
care, they are excited for this milestone in their personal development (Doulton, 2010).  
Additionally, research has found that as the patient becomes more familiar with  adult providers 
and are recognized as an adult, they often grow to find acceptance with transitioning (Bryant, et 
al., 2011; Tuchman, et al., 2008).   
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 5.2 SPECIFIC AIM 2 
Factors such as, self-reliance, the patient’s understanding of the disease, educational and socio-
economic levels, and disease severity and complications can impact successful transition 
(Sobota, et al., 2014).  This study aimed to assess patients’ readiness for transition by eliciting 
their level of independence with regards to their perceptions of their knowledge and skills that 
are crucial for transition.   This information is important to gather and assess given that is has 
been proposed that the greatest barrier to transition may be insufficient knowledge regarding the 
process (McPherson, et al., 2009).  Subsequently, understanding patients’ perceptions of their 
level of knowledge, as well as their actual knowledge base, is an essential component of 
successful transition to adult-oriented care given that it influences anticipatory guidance.   
In this study, patients appeared to have similar levels of independence in skills pertaining 
to “Knowledge of Health Issues/Diagnosis, “Being Prepared”, and “Taking Charge”. These 
similarities in levels of independence could be an artifact of the limited number of patients that 
were surveyed, and analysis of a larger sample of patients may potentially reveal distinct 
variations between these skill sets. However, despite the small sample size, there was still a 
significantly lower level of independence in skills related to “Preparing for Legal/Other Issues 
After Age 18”. This difference may be due to the fact that in the clinical setting, health care 
professionals more often work to address issues pertaining to the actual medical condition (i.e. 
symptoms, appointments, and medications), rather than legal issues.  Nonetheless, the literature 
has shown that it is vital that providers ensure that patients and families are prepared for, and 
understand the legal issues associated with the transition into adulthood.  Youth with special 
health care needs are particularly affected by legal changes such as support-service or program 
eligibility changes, consent and confidentiality provisions, and issues related to insurance 
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 coverage and payment for health care services (American Academy of Pediatrics, et al., 2011).  
In turn, a recommendation for the CHP Sickle Cell transition program would be to provide 
patients with resources regarding legal/other issues after age 18, whether it be in the form of a 
hard copy of written materials, web-based materials, and/or an educational discussion with a 
social worker.  
In addition, previous studies on transition have consistently called for the utilization of 
patient readiness assessment tools (McPherson, et al., 2009; Sobota, et al., 2014), followed by 
reassessment of the general transition plan in order to tailor to the specific needs of the patient 
and family. Therefore, transition should be viewed as a continuum, and the process should be 
started early in order to ensure adequate time for patients to reach an appropriate level of 
readiness.  In turn, continued monitoring and addressing of items in which the patient states 
he/she needs assistance with to achieve independence will be essential in the transition process of 
the patients involved in this study. 
Lastly, overall level of independence/readiness was found to not be influenced by 
patients’ age, gender, or disease type in this study. This finding may have also been subject to 
sample size, given that previous research has shown that an older age at the start of transition 
negatively influenced transition success.  Furthermore, patients with SC and Sβ+ were shown to 
be more likely to unsuccessfully transition (Andemariam, et al., 2014).  Given that age, gender, 
and disease type/severity did not influence the level of independence/readiness in our sample, 
there may be other factors that also play into determining the successfulness of the transition 
process.   Moreover, results from this project as well as other studies have demonstrated that 
there are emotional and psychological factors that play into transition, and steps must be made to 
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 also evaluate and address these issues (Smith, et al., 2011; Tuchman, et al., 2008; Wills, et al., 
2010). 
5.3 STUDY LIMITATIONS 
One limitation of this study is its generalizability.  The results of this study are based on a small 
sample of patients.  The limited number of patients makes it difficult to generalize the data and 
findings to the entire CHP patient population.  This is especially true when looking at the 
demographic data and the skill set analysis done based on the demographic characteristics.  
Furthermore, due to small sample size, outliers may significantly skew the results.     
Another limitation is that the data collected and the analysis that could be performed from 
the data is dependent upon what patients chose to report.  The degree to which patients’ 
perspectives on transition could be assessed was reliant upon how much detail they put into the 
open-ended responses. Moreover, there were several surveys in which patients left one or more 
questions unanswered.   This makes it difficult to fully interpret the data that was collected.  
Conversely, use of an adapted version of the customizable, standardized readiness assessment 
tool provided by Got Transition was a strength in regards to the data that was collected and 
analyzed. 
Lastly, the patients involved in this study attend a uniquely designed sickle cell specialty 
clinic, which also has a close relationship with an adult hematology program. The perspectives 
and experiences of the patients in this study may not be an accurate representation of those held 
by all sickle cell patients in a pediatric setting preparing to transition to adult oriented care.  
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 5.4 FUTURE CONSIDERATIONS 
The results of this study provided some initial information regarding expectations and concerns 
of sickle patients regarding transition, and the level of independence they possess for various 
skills necessary to transition to an adult setting. The findings suggest possible recommendations 
for strategies that can be utilized by the transition program at the CHP Sickle Cell Clinic to 
address the obstacles to transition identified in the study.  Consequently, an important next step 
would be to directly ask patients what they would want provided to them by the transition 
program in order to facilitate a more successful transition process. 
  Further research into the effectiveness of early and ongoing preparation for adult 
transition is still warranted.  The survey instrument utilized in this study will be used 
longitudinally by the CHP Sickle Cell Clinic, to determine what factors positively impact the 
process of transition from pediatric to adult sickle cell disease health care. Additionally, it will be 
important to study patients who do not make successful transitions to adult oriented care in order 
to further identify and address barriers to transition.  The development of a standardized survey 
used nationwide would provide greater insight into how other sickle cell centers are conducting 
transitions for their patients, and would help overcome the limitations associated with small 
sample size.   
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 6.0  CONCLUSIONS 
In conclusion, this project successfully met its specific aims.  Eliciting sickle cell patients’ 
expectations and concerns regarding transition, as well as evaluating their perceptions of 
knowledge and skills,  generated understanding about  potential barriers to transition to adult 
care. This information can inform the development of a plan to address these obstacles and 
provide a more successful transition process.  From a public health perspective, sickle cell 
patients are typically transferred to adult health care providers around age 18 to 20 years.  
However, patients in the age of transition are often at an increased risk for significant disease 
complications, and young adults (18–30 years) with sickle cell disease often demonstrate a high 
need for hospital-based care (DeBaun & Telfair, 2012; de Montalembert, et al., 2014).  In fact, 
individuals in this age group typically have a greater number of emergency room visits, in-
patients stays, and acute care visits than their adolescent (10-17 years) and older adult (31-45 
years) peers (Lebensburger, et al., 2012).  In turn, transition from pediatric to adult care 
providers is a crucial step in the care of individuals with sickle cell disease, and the need for a 
strong transition program is essential.  
 
 
 
 44 
 APPENDIX A: IRB Approval Letter 
 45 
  
 46 
 APPENDIX B: TRANSITION QUESTIONAIRRE (SECTION 2) 
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 A FEW THOUGHTS ABOUT TRANSITION 
 
What are the good things 
about transitioning? 
 
 
 
 
 
What are the not so good 
things about transitioning? 
 
 
 
 
 
 
What is the best thing that  
will happen to you when you 
transition? 
 
 
 
 
 
 
What is the worst thing that 
you see happening to you 
when you transition? 
 
 
 
 
Can you state at least one 
thing that you have done in 
the past 6 months to improve 
the transition process? 
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 APPENDIX C: TRANSITION QUESTIONAIRRE (SECTION 4) 
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 VISIT EVALUATION WITH SICKLE CELL TEAM (SCD SPECIFIC) 
C.1 KNOWLEDGE OF HEALTH ISSUES/DIAGNOSIS 
1. I can explain the type of sickle cell disease that I have. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
2. I understand my diagnosis and health history, and can explain it to others. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
3. I know and can state my significant health problems caused by my sickle cell 
disease. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
4. I know what my other non-sickle cell diagnoses are. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
5. I can explain my health care needs and medical treatments to a new provider. 
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 • I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
6. I can tell a new provider what medication I have been prescribed. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
7. I can state the dose and how often I take the medication. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
8. I know how to pick up my medicine from the pharmacy. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
9. I can inform the provider what specialists I have seen. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
10. I know when I last saw each specialist. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
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 11. I know my hemoglobin and retic level baseline. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
12. I know my pulse oximeter baseline number. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
13. I know my symptoms that need quick medical attention. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
14. I know what to do in case I have a medical emergency. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
C.2 BEING PREPARED 
1. I carry my health insurance card every day. 
• I can do this independently 
• I am currently learning to do this independently 
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 • I always depend on others to do this for me 
2. I know what type of Medical Coverage I have (i.e. Medicaid, UPMC, Gateway, etc.) 
and I know the basic services that are covered. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
3. I either carry or know where to get my important health information (i.e. medical 
summary, including medical diagnosis, list of medications, allergy info, doctor’s 
numbers, drug store number, etc.). 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
4. Do you have an adult Primary Care Physician (If you are over 18)? 
• Yes 
• No 
C.3 TAKING CHARGE 
1. I call and make my own doctor’s appointments. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
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 2. I use a cell phone or calendar to remind me of appointments and refills. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
3. I know I have an option to see my doctor by myself. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
4. Before a doctor’s appointment I prepare written questions to ask. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
5. I track my own appointment and prescription refill expiration dates. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
6. I can read a prescription label. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
7. I call in my own prescription refills. 
• I can do this independently 
• I am currently learning to do this independently 
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 • I always depend on others to do this for me 
8. I can state where I typically experience pain during a pain episode. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
9. I know how to manage my pain and diagnosis at home. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
10. I know what medication helps to manage my pain. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
11. I know how to take my medications to manage my pain. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
12. I know what non-medication steps to take to help manage my pain. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
13. I know stress reduction or relaxation techniques that help my pain. 
• I can do this independently 
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 • I am currently learning to do this independently 
• I always depend on others to do this for me 
C.4 PREPARING FOR LEGAL/OTHER ISSUES AFTER AGE 18 
1. I have a plan so I can keep my health care insurance or obtain medical coverage 
after I turn 18. 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
2. I have a plan to develop a legal Power of Attorney for health care decisions in the 
event my health changes and I am unable to make decisions for myself. (Everyone in 
the family should have one!) 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
3. Do you know of resources that can help you find adult services (job support, 
transportation, assistive technology, etc.)? 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
4. Do you know how your condition may affect your job choices? 
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 • I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
5. Do you know what benefits you might qualify for (SSI, Community Based Services 
etc.)? 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
6. Do you know your options for housing as an adult (on your own, group home)? 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
7. Do you know how to manage money and pay your bills? 
• I can do this independently 
• I am currently learning to do this independently 
• I always depend on others to do this for me 
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